Skip to content

The Development and Application of a Clinical Decision Support System for Osteonecrosis of the Femoral Head Based on Multimodal Data Fusion AI Technology

The Development and Application of a Clinical Decision Support System for Osteonecrosis of the Femoral Head Based on Multimodal Data Fusion AI Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091552
Enrollment
Unknown
Registered
2024-10-30
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteonecrosis of the femoral head

Interventions

Gold Standard:hip joint magnetic resonance imaging (MRI)
Index test:CDSS for osteonecrosis of the femoral head based on multimodal data fusion AI technology

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with osteoncrosis of the femoral head by MRI, age between 18-65 years old of any gender.

Exclusion criteria

Exclusion criteria: The primary disease is severe and not suitable for participants in this study; Pregnant or lactating women; Individuals with allergic constitution and multiple drug allergies; Patients with severe cardiovascular and cerebrovascular diseases, liver and kidney dysfunction (liver function tests ALT or AST exceeding twice the upper limit of normal values, kidney function tests creatinine or urea nitrogen exceeding the upper limit of normal values), hematopoietic system diseases, severe gastrointestinal diseases, and severe underlying mental and central nervous system diseases; Individuals with bleeding tendency or vascular dysfunction; Not suitable for individuals undergoing magnetic resonance imaging (such as those with claustrophobia, pacemakers, metal contraceptive rings, etc.); Researchers believe that other situations are not suitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
guideline coincidence rate;

Secondary

MeasureTime frame
decision change rate;

Countries

China

Contacts

Public ContactGao Fuqiang

China-Japan Friendship Hospital

gaofuqiang@bjmu.edu.cn+86 189 0126 7995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026